ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)	1 Months Ended	12 Months Ended
	Dec. 29, 2011	Dec. 31, 2012		Dec. 31, 2011		Nov. 30, 2011	Dec. 31, 2010	Dec. 31, 2009
Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares	281,250
Convertible Preferred Stock, Shares Issued upon Conversion	8.89
Deficit accumulated in development stage		$ 18,925,793		$ 853,074
Cash and Cash Equivalents, At Carrying Value		16,455,995		9,748,491		0	0	0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		10,746,837		5,320,173
Business acquisition shares not surrendered	132,000
Business Acquisition Shares Repurchased Percentage	95.00%
In-process research and development		2,797,600		3,902,300
Goodwill		799,391		799,391
Notes payable, noncurrent portion, at fair value		2,479,098		3,294,797
Period Anticipated Sufficient To Fund Operating Cash Flow		18 months
Stockholders' Equity, Reverse Stock Split		Ratio of 56.25 for 1
Decrease To Total Assets And Liabilities				1,369,900
Cash Equivalents Maturity Period		less than three months
Before Correction Of Immaterial Error [Member]
In-process research and development				5,441,839
Goodwill				629,752
Notes payable, noncurrent portion, at fair value				4,664,697
After Correction Of Immaterial Error [Member]
In-process research and development				3,902,300
Goodwill				799,391
Notes payable, noncurrent portion, at fair value				3,294,797
Series Preferred Stock [Member]
Convertible Preferred Stock, Shares Issued upon Conversion	8.89	8.89
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period		0	[1]	129,375	[1]
Series Preferred Stock [Member] | Mr.Power [Member]
Convertible Preferred Stock, Shares Issued upon Conversion	8.89
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period	16,875
Series Preferred Stock [Member] | Mr.Weiss [Member]
Convertible Preferred Stock, Shares Issued upon Conversion	8.89
Percentage Of Outstanding Shares Granted Annually	1.25%
Percentage Of Annual Grants Restricted Stock Becoming Non Forfeitable On First Aniversary	25.00%
Percentage Of Annual Grants Restricted Stock That Will Vest And Become Nonforfeitable On Second Aniversary	25.00%
Market Capitalization Increase To Trigger Restricted Stock That Will Vest And Become Nonforfeitable	100,000,000
Percentage Of Restricted Stock That Will Vest And Become Nonforfeitable Upon Market Capitalization Increase	50.00%
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period	112,500
Tg Bio [Member]
Percentage Of Stock Issued After Exchange Transaction	95.00%

[1] (1) The restricted preferred stock listed in the table above was granted in connection with the Exchange Transaction to certain executives as discussed above. Each share of preferred stock was convertible into 8.89 shares of the Company's Common Stock. In conjunction with the reverse split effected on April 30, 2012 (as discussed in Note 1), all outstanding restricted Preferred Stock automatically converted to 1,150,000 shares of restricted Common Stock as of that date.